French pharmaceutical giant Sanofi is set to acquire U.S.-based Blueprint Medicines Corporation in a deal worth up to $9.5 billion, marking one of the largest European healthcare transactions of ...

Sanofi has agreed to acquire Blueprint Medicines for up to approximately $9.5 billion, the companies said today, in a deal designed to expand the buyer’s rare immunological disease portfolio ...

Sanofi faces setbacks after itepekimab’s Phase 3 COPD failure, removing a key growth prospect and highlighting reliance on Dupixent. Read more about why SNY is still a Buy.

Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.

Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company ...

Sanofi stated that its investment decisions “will be adjusted as the external environment continues to evolve”. In 2024, $21.6bn of its $45.2bn global sales came from the US market.

Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant increase in research and development spending ...

Sanofi has agreed to pay up to $465 million in milestones for exclusive rights to the latest program. The potential paydays add to the $1.9 billion that Nurix was eligible for at the end of November.

Sanofi scored 7.5 points, beating AbbVie by 5 points. Takeaway. As in the previous two comparative articles, my main goal was to determine who is better, AbbVie or Sanofi, in the long term.

In the 14-week phase 2b study by Sanofi and Teva's U.S. affiliate held in the U.S., Europe and Israel, the drug, called duvakitug, showed that 36.2% of low dose and 47.8% of high dose patients ...

In a March 2022 summit in Dubai, organised by Sanofi Greater Gulf and attended by over 200 dermatologists, ... Shea butter and glycerin are also great for moisturising and protecting the skin. ...